A comparative double blind trial of pimozide and fluphenazine in chronic schizophrenia.
D001562:Benzimidazoles / Q000009:adverse effects / Q000627:therapeutic use*; D001772:Blood Cell Count; D002986:Clinical Trials as Topic; D005476:Fluphenazine / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009966:Orphenadrine / Q000627:therapeutic use; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy*; D014149:Tranquilizing Agents / Q000009:adverse effects / Q000627:therapeutic use*
D001562:Benzimidazoles; D014149:Tranquilizing Agents; D009966:Orphenadrine; D005476:Fluphenazine